RMC No. 131-2024: Updated VAT-Exempt Medicine List for Cancer, Diabetes, and Mental Illness Products

RMC No. 131-2024 updates the VAT-exempt medicine list for cancer, diabetes, and mental illness products, with effectivity tied to FDA publication. Businesses selling, dispensing, importing, distributing, or accounting for qualified medicines must immediately check the latest FDA-published list of VAT-exempt medicines because the VAT exemption under the CREATE Act takes effect based on the FDA’s […]

RMC No. 93-2024: Updates to VAT-Exempt Medicines Following FDA Letter on TRAIN and CREATE Acts

RMC No. 93-2024 publishes FDA-endorsed updates to the VAT-exempt list of medicines under TRAIN and CREATE Acts, including additions and deletions, effective upon FDA publication. Businesses and tax practitioners handling pharmaceuticals must review the updated VAT-exempt list as endorsed by the Food and Drug Administration (FDA) and published by the Bureau of Internal Revenue. This […]

RMC No. 19-2023: VAT Exemption Updates for FDA-Endorsed Medicines and Medical Devices Under TRAIN and CREATE

RMC No. 19-2023 confirms FDA-endorsed VAT-exempt medicine and medical device updates, with CREATE Act exemption effective from FDA publication date. Businesses selling, purchasing, importing, prescribing, distributing, or accounting for VAT-exempt medicines and medical devices must verify whether their products are included in the Food and Drug Administration’s updated VAT-exempt list, because VAT exemption under the […]

RMC No. 124-2022: VAT-Exempt Medicines Updated for Cancer, Tuberculosis, Mental Illness, Diabetes, and Hypertension Under CREATE

RMC No. 124-2022 updates VAT-exempt medicines under CREATE for cancer, tuberculosis, mental illness, diabetes, and hypertension based on FDA publication. Businesses selling, importing, prescribing, dispensing, accounting for, or claiming VAT treatment on covered medicines must check the updated VAT-exempt medicine list immediately because the exemption applies based on the date the Food and Drug Administration […]

RMC No. 58-2022: Updates to VAT-Exempt Medicines List Including Hypertension and COVID-19 Treatments

RMC No. 58-2022 publishes FDA corrections to VAT-exempt medicines, affecting hypertension and COVID-19 treatments. Businesses must update records and invoices to remain compliant. Businesses and healthcare providers must immediately note changes to the VAT-exempt status of certain medicines. RMC No. 58-2022 publishes the FDA’s updates correcting names of specific medicines used for hypertension and COVID-19 […]

RMC No. 57-2022: VAT Exemption Expanded to Include Hypertension, Diabetes, and COVID-19 Medicines

RMC No. 57-2022 updates the VAT-exempt list under the CREATE Act to include medicines for hypertension, diabetes, and COVID-19, requiring businesses to adjust invoicing and VAT reporting. Businesses and healthcare providers must immediately account for the updated VAT-exempt status of certain medicines for hypertension, diabetes, and COVID-19, effective from April 27, 2022. Failure to recognize […]

RMC No. 30-2022: Updated VAT-Exempt Medicines List for Cancer, Diabetes, Hypertension, High Cholesterol, Mental Illness, and COVID-19

RMC No. 30-2022 updates the VAT-exempt medicines list under CREATE, covering specified medicines and requiring sellers to review VAT treatment. Pharmacies, hospitals, clinics, drug distributors, importers, and VAT-registered sellers of medicines must immediately verify whether the medicines they sell, dispense, import, or purchase are included in the updated VAT-exempt medicines list endorsed by the Food […]

RMC No. 2-2022: Updated VAT-Exempt COVID-19 Medicines Endorsed by DOH for Philippine Tax Compliance

RMC No. 2-2022 updates the list of VAT-exempt COVID-19 medicines under RA 11534, affecting pharmacies, hospitals, and suppliers. Businesses must adjust VAT treatment immediately. Businesses must now ensure their VAT compliance reflects the latest list of COVID-19 medicines that are exempt from value-added tax under Republic Act No. 11534. The Department of Health has officially […]

RMC No. 123-2021: Updated VAT-Exempt COVID-19 Medicines and Vaccine List for Pharmacies, Importers, Hospitals, and Healthcare Suppliers

RMC No. 123-2021 updates the VAT-exempt COVID-19 medicines and vaccine list, affecting pharmacies, hospitals, importers, and healthcare suppliers. Pharmacies, hospitals, healthcare suppliers, importers, distributors, wholesalers, and retailers dealing in COVID-19 medicines must immediately check their product master lists, invoices, point-of-sale systems, and importation records against the updated VAT-exempt list published under RMC No. 123-2021. The […]